3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Liver Neoplasms
1
Hepatitis B
1
Drug-Related Side Effects and Adverse Reactions
1
Carcinoma, Hepatocellular
1
Interventions
Oxaliplatin
21
Capecitabine
19
Fluorouracil
16
Bevacizumab
16
Esomeprazole
11
Sorafenib
10
Irinotecan
9
Leucovorin
8
Radiofrequency Ablation
7
Propofol
7
Bismuth
7
Morphine
6
Gemcitabine
6
Folfox protocol
6
Amoxicillin
6
lenvatinib
5
gadolinium ethoxybenzyl DTPA
5
Tetracycline
5
Sevoflurane
5
S 1 (combination)
5
Drug Therapy
5
Control Groups
5
Cisplatin
5
sodium glycididazole
4
fish oil triglycerides
4
ferric carboxymaltose
4
Sodium Chloride
4
Ropivacaine
4
Ribavirin
4
Hepatectomy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Telbivudine
×
Gastrointestinal
×
Clear all
NCT01102335
2010-04-13
TACEHBV
Fudan University
Phase 4
Unknown
80 enrolled